RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Celltrion Pharm Stock

Celltrion Pharm ROA 2024

Celltrion Pharm ROA

0

Ticker

068760.KQ

ISIN

KR7068760008

In 2024, Celltrion Pharm's return on assets (ROA) was 0, a -100% increase from the 0.04 ROA in the previous year.

Celltrion Pharm Aktienanalyse

What does Celltrion Pharm do?

Celltrion Pharm ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Celltrion Pharm's Return on Assets (ROA)

Celltrion Pharm's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Celltrion Pharm's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Celltrion Pharm's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Celltrion Pharm’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Celltrion Pharm stock

What is the Return on Assets (ROA) of Celltrion Pharm this year?

The Return on Assets (ROA) of Celltrion Pharm is 0 undefined this year.

What was the ROA of Celltrion Pharm compared to the previous year?

The ROA of Celltrion Pharm has increased by -100% compared to the previous year.

What consequences do high ROA have for investors of Celltrion Pharm?

A high ROA is advantageous for investors of Celltrion Pharm, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Celltrion Pharm?

A low ROA can be unfavorable for investors of Celltrion Pharm as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Celltrion Pharm affect the company?

An increase in ROA of Celltrion Pharm can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Celltrion Pharm impact the company?

A reduction in the ROA of Celltrion Pharm can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Celltrion Pharm?

Some factors that can influence the ROA of Celltrion Pharm include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Celltrion Pharm important for investors?

The ROA of Celltrion Pharm is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Celltrion Pharm take to improve ROA?

To improve ROA, Celltrion Pharm can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Celltrion Pharm pay?

Over the past 12 months, Celltrion Pharm paid a dividend of 149.07 KRW . This corresponds to a dividend yield of about 0.28 %. For the coming 12 months, Celltrion Pharm is expected to pay a dividend of 0 KRW.

What is the dividend yield of Celltrion Pharm?

The current dividend yield of Celltrion Pharm is 0.28 %.

When does Celltrion Pharm pay dividends?

Celltrion Pharm pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Celltrion Pharm?

Celltrion Pharm paid dividends every year for the past 0 years.

What is the dividend of Celltrion Pharm?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Celltrion Pharm located?

Celltrion Pharm is assigned to the 'Health' sector.

Wann musste ich die Aktien von Celltrion Pharm kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Celltrion Pharm from 4/18/2007 amounting to 200 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2006.

When did Celltrion Pharm pay the last dividend?

The last dividend was paid out on 4/18/2007.

What was the dividend of Celltrion Pharm in the year 2023?

In the year 2023, Celltrion Pharm distributed 0 KRW as dividends.

In which currency does Celltrion Pharm pay out the dividend?

The dividends of Celltrion Pharm are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Celltrion Pharm

Our stock analysis for Celltrion Pharm Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Celltrion Pharm Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.